TG2 can inhibit apoptosis in cancer cells also by directly inhibiting caspase-3 activity via forming a crosslinked multimer, or by upregulating NF-κB activity, which transcribes anti-apoptotic proteins [67]. Here, NFKB1 is linked to cancer.